Kamada (KMDA) Goodwill & Intangibles (2020 - 2026)
Kamada's (KMDA) quarterly Goodwill & Intangibles came in at $94.0 million in Q2 2026, down 5.69% on a YoY basis from $99.6 million in Q2 2025, and down 1.79% quarter-over-quarter from $95.7 million in Q1 2026.
Analysis
Kamada (KMDA) Goodwill & Intangibles (2020 - 2026) Analysis & Trends
Kamada (KMDA) has reported Goodwill & Intangibles for 7 consecutive years, with $94.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Goodwill & Intangibles fell 5.69% year-over-year to $94.0 million; the trailing twelve-month figure through Jun 2026 stood at $94.0 million (down 5.69% YoY), and the FY2025 full-year result was $97.5 million, down 5.54% from the prior year.
- Goodwill & Intangibles fell to $94.0 million in Q2 2026 per KMDA's latest filing, from $95.7 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $151.9 million in Q1 2022 and bottomed at $94.0 million in Q2 2026.
- Historically, Goodwill & Intangibles has averaged $119.5 million across 5 years, with a median of $107.4 million in 2024.
- The sharpest annual moves came in 2022 and 2024: Goodwill & Intangibles jumped 4308.12% in 2022, then dropped 26.51% in 2024.
- Over 5 years, Goodwill & Intangibles stood at $147.1 million in 2022, then dropped by 25.1% to $110.2 million in 2023, then dropped by 6.29% to $103.2 million in 2024, then retreated by 5.54% to $97.5 million in 2025, then slipped by 3.63% to $94.0 million in 2026.
- According to Business Quant data, Goodwill & Intangibles over the past three periods registered $94.0 million, $95.7 million, and $97.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn |
| 10 | Kamada | 473.57 Mn | 403.43 Mn | 22.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 93.97 Mn |
| Mar 31, 2026 | 95.68 Mn |
| Dec 31, 2025 | 97.51 Mn |
| Sep 30, 2025 | 99.19 Mn |
| Jun 30, 2025 | 99.64 Mn |
| Mar 31, 2025 | 101.42 Mn |
| Dec 31, 2024 | 103.23 Mn |
| Sep 30, 2024 | 104.73 Mn |
| Jun 30, 2024 | 106.52 Mn |
| Mar 31, 2024 | 108.31 Mn |
| Dec 31, 2023 | 110.15 Mn |
| Sep 30, 2023 | 142.50 Mn |
| Jun 30, 2023 | 143.99 Mn |
| Mar 31, 2023 | 145.31 Mn |
| Dec 31, 2022 | 147.07 Mn |
| Sep 30, 2022 | 148.62 Mn |
| Jun 30, 2022 | 150.45 Mn |
| Mar 31, 2022 | 151.86 Mn |
| Dec 31, 2021 | 121.17 Mn |
| Sep 30, 2021 | 3.38 Mn |